Download PDF
643 € million in sales
54% export
(100 countries)
1,335 employees
10 facilities
Ercros: centennial-old tradition that looks into the future

Ercros is an industrial group diversified into three business areas: the Chlorine Derivatives Division, a strategic unit whose common nexus is chlorine; the Intermediate Chemicals Division, focused on formaldehyde chemistry; and the Pharmaceuticals Division, dedicated to pharmaceutical active ingredients. It is a leading company in the main markets in which it operates for most of its products.

The principles that guide their activity are the safety of their facilities and the health of their people, respect for the environment, the quality of their products, and dialogue and transparency with society.

It is listed on the continuous market of the Spanish stock exchange.

Sales and adjusted ebitda of each division (€M)
Main raw materials
Main products
Competitive position
Spain
Europe
World
Chlorine derivatives
TCCA
1st
1st
-
Sodium chlorate
1st
4th
-
Sodium hypochlorite
1st
11th
-
Caustic potash
1st
7th
-
PVC
1st
9th
-
Caustic soda
1st
9th
-
Intermediate chemicals
Glues and resins
2nd
7th
-
Formaldehyde
1st
5th
-
Paraformaldehyde
1st
1st
1st
Polyols
1st
2nd
3rd
Moulding compounds
1st
2nd
3rd
Pharmaceuticals
Fusidic acid
-
2nd
2nd
Fosfomycins
1st
2nd
3rd
Erythromycins
1st
1st
-
Currencies and markets (2024)
Currencies and markets of Ercros
Currency cake
Markets cake
Markets of the divisions
Key figures (€M)
Results account
2023
2024
Continuing operations    
Income
757.6
700.4
  Sales of goods
707.2
643.4
  Services rendered
18.1
23.9
  Other incomes and increase in finished goods
31.1
27.6
  Reversal of provisions
1.2
5.4
Expenses
-713.3
-670.9
  Supplies and utilities ("S&U")
-528.8
-487.5
  Staff costs
-91.6
-100.9
  Other expenses and reduction in finished goods
-88.0
-77.9
  Provisions
-5.0
-4.6
Ebitda
44.3
29.4
Amortizations and impairments of assets
-31.3
-32.5
Financial results
-8.0
-9.1
Profit before tax
5.0
-12.2
Income taxes
23.8
0.6
Result from continuing operations
28.8
-11.7
Result from discontinued operations
-1.2
-
Result for the year
27.6
-11.7
Balance sheet
31-12-2023
31-12-2024
Non-current assets
419.2
403.8
Working capital
64.2
98.0
Equity
363.1
341.1
Net financial debt ("NFD")
90.1
133.6
Provisions and other borrowings
30.2
27.1
Distribution of free cash flow (2024)
Appropriation profit (2023)
The share
Market capitalisation
(15-04-25) (EUR M)
269.3
Volume
(15-04-25) (shares)
34,910
Share capital
(15-04-25) (EUR M)
27.43
Number of shares
(15-04-25) (million shares)
91.4
Ratios
Financial
31-12-2023
31-12-2024
Leverage [NFD ÷ total equity]
0.25
0.39
Solvency [NFD ÷ adjusted ebitda]
1.87
4.67
Liquidity [current assets ÷ current liabilities]
1.28
1.15
ROCE [ebit ÷ resources used] (%)
2.70
-0.63
Operating
   
Productivity [value added ÷ n. of employees] (€/person)
101,899
97,634
Margin of contribution/sales [(sales + provision of services + S&U + stock reduction) + (sales + provision of services)] (%)
31.80
33.70
Margin of adjusted ebitda/sales (%)
6.63
4.29
Stock
   
EPS [profit ÷ n. of shares] (€)
0.29
-0.13
PER [capitalization ÷ profit]
8.75
-
ESG Indicators
 
2023
2024
Women (% headcount)
18.3
19.4
Capex (€M)
27.7
27.7
Sustainability expenditure (€M)
19.1
17.6
Expenses and investment in R+D (€M)
6.6
6.7
Training (annual hours/person)
26.7
24.2
Accident frequency rate
2.7
2.8
CO2 emissions index (% change vs previous year)
-8.1
-0.8
Energy consumption (% change vs previous year)
-3.0
-5.9
Contact us
Contact: ercros@ercros.es
Web: www.ercros.es
Supplied by ©